Led by Blue Venture Fund, the new funding will accelerate Oxford-based Ultromics’ use of AI-enabled echocardiograms to improve patient outcomes.
The funding round included existing investors RA Capital Management, Oxford Sciences Innovation (OSI) and CureDuchenne Ventures and a host of new investors.
The c.28,000 sq ft building, let in its entirety to the Oxford Science Innovation (OSI), was acquired from MRP, the property arm of construction firm McAleer & Rushe.
Weighing 25,000kg, the new 38mm gun fires a 100g projectile, which can reach a maximum velocity of 6.5km/s or 14,500mph – 20 times the speed of sound.
The raise will enable the company to complete development work and gain first in-human data through an early feasibility clinical study.
The Corporate Co-working Membership scheme will give businesses the chance to offer employee collaboration at a convenient workspace close to home.
The round was co-led by Epidarex Capital and Taiho Ventures LLC with participation from existing investor, Oxford Sciences Innovation (OSI).
The biotech start-up company based in Upper Heyford will use the funds to accelerate the development of its novel antibody therapeutics for inflammatory disease.
The funding round was led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor, University of Oxford and CureDuchenne.
Bidwells, the commercial property consultancy – has estimated that organisations within Oxfordshire’s Science & Tech community have raised over £1bn in funding to date during 2020.
Oxford Sciences Innovation (OSI) has announced the sale of its portfolio company, Base Genomics, to Exact Sciences for a total consideration of $410m.